HSBC Holdings
CMPX icon

HSBC Holdings’s Compass Therapeutics CMPX Stock Holding History

HSBC Holdings’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,923
Closed -$23.3K – 3056
2025
Q1 		$23.3K Sell
11,923
-9,606
-45% -$25.5K ﹤0.01% 2960
2024
Q4 		$32.1K Sell
21,529
-931
-4% -$1.55K ﹤0.01% 3034
2024
Q3 		$40.9K Buy
22,460
+3,414
+18% +$4.25K ﹤0.01% 2902
2024
Q2 		$21.7K Buy
19,046
+8,570
+82% +$12.5K ﹤0.01% 2871
2024
Q1 		$20.7K Sell
10,476
-21,669
-67% -$37.4K ﹤0.01% 2989
2023
Q4 		$47.9K Buy
+32,145
New +$55.6K ﹤0.01% 2652

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings's CMPX Position: Q2 2025 in Review

HSBC Holdings sold out of Compass Therapeutics (CMPX) in Q2 2025, closing a stake of 11,923 shares — an estimated $23.3K sold.

HSBC Holdings first reported a position in CMPX in Q4 2023 and held it in 6 quarters. The position peaked at $47.9K in Q4 2023. 103 funds tracked by Wall St. Rank hold CMPX as of Q2 2025.

  • HSBC Holdings reported no remaining Compass Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 11,923 Compass Therapeutics shares in Q2 2025, an estimated $23.3K.
  • HSBC Holdings first reported a position in Compass Therapeutics in Q4 2023 and held it in 6 quarters.
  • HSBC Holdings's Compass Therapeutics position peaked at $47.9K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.